Seth Rudnick Insider Profile
4 Followers
Seth Rudnick, Director at Liquidia Technologies, holds ― shares in Liquidia Technologies (Ticker: LQDA), holds 9.65K shares in G1 Therapeutics (Ticker: GTHX), holds 64.39K shares in Aralez Pharmaceuticals (Ticker: ARLZQ).
Seth Rudnick's Trading History
| GTHXG1 Therapeutics | Jun 30, 2021 | ― | Uninformative Buy | 3.72K | $69.03K | |
| ARLZQAralez Pharmaceuticals | May 12, 2017 | ― | Uninformative Buy | ― | $128.78 | |
| EPRSQEpirus Biopharma | ― | ― | ― | $0.00 | ||
| LQDALiquidia Technologies | ― | Director | ― | ― |
You May Also Like
Seth Rudnick insider profile FAQ
What is the percentage of profitable transactions made by Seth Rudnick?
The percentage of profitable transactions made by Seth Rudnick is 0%.
What is the average return per transaction made by Seth Rudnick?
The average return per transaction made by Seth Rudnick is -43.90%.
What stocks does Seth Rudnick hold?
Seth Rudnick holds: LQDA, ARLZQ, GTHX, EPRSQ stocks.
What was Seth Rudnick's most profitable transaction?
Seth Rudnick’s most profitable transaction was an Informative Buy of ARLZQ stock on March 17, 2017. The return on the trade was -18.60%.
What is Seth Rudnick's role in Liquidia Technologies?
Seth Rudnick's role in Liquidia Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
